Skip to main content
Premium Trial:

Request an Annual Quote

Exiqon, MultiD Ink Deal to Provide miRNA qPCR Analysis Solution

Premium

Exiqon has signed a development and distribution deal with MultiD Analyses to adapt MultiD's GenEx qPCR analysis software for Exiqon's new microRNA qPCR platform, the companies said this week.

Exiqon said the deal allows it to sell a fully compatible and comprehensive miRNA qPRC data-analysis solution.

The partnership between the companies has resulted in "a customized version" of GenEx, which "has been specifically adapted to allow easy pre-processing and analysis of data from the Exiqon microRNA PCR panels and assays," Exiqon Vice President of sales and marketing Henrik Pfundheller said in a statement.

In addition, MultiD has developed a special plate design module that enables Exiqon's customers "to design their qPCR experiment in silico and generate templates for import into their real-time PCR instrument," MultiD Chairman Mikael Kubista said. "These templates also allow fast and easy import of the results into GenEx for pre-processing and analysis."

Specific terms of the arrangement were not disclosed.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.